endometrial cancer
Conditions
Interventions
oART:Using an integrated CT linear accelerator (uRT-linac 506c) for postoperative online adaptive radiotherapy of endometrial cancer.
Sponsors
Peking University Third Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Voluntarily agree to participate in this study and sign a written informed consent form prior to treatment. 2.Postoperative pathological diagnosis of endometrial carcinoma with indications for adjuvant radiotherapy. 3.Postoperative imaging assessment confirming absence of distant metastasis. 4.Karnofsky score >= 60. 5.Age 18–85 years. 6.Able to comply with study requirements, demonstrate good adherence, and agree to follow-up.
Exclusion criteria
Exclusion criteria: 1.Prior pelvic radiotherapy. 2.Requirement for simultaneous lymph node or parametrial boost. 3.Concurrent serious organic diseases that would impair tolerance or markedly increase radiotherapy risk, including but not limited to central nervous system disorders, severe cardiac disease (e.g., unstable angina, recent myocardial infarction, NYHA class III–IV heart failure), severe hepatic insufficiency, severe renal failure, significant coagulopathy, or active infections requiring strict control. 4.Interruption of current treatment for any reason or anticipated inability to complete the planned radiotherapy course. 5.Participation in another clinical trial or currently within another trial’s observation/follow-up period. 6.Inability to comply with post-treatment follow-up. 7.Any other condition deemed by the investigator to make the subject unsuitable for participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment Duration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dosimetric Parameters; | — |
Countries
China
Contacts
Public ContactAng Qu
Peking University Third Hospital
Outcome results
None listed